Global softgel capsule market

Softgel Capsule Market Size, Share, Growth Analysis, By Type(Gelatin/ Animal based, non-animal based), By Application(Antacid & anti flatulent preparations, Anti anaemic preparations, Anti inflammatory drugs, Antibiotics & antibacterial drugs), By Manufacturers(Pharmaceutical companies, Nutraceutical companies, Cosmeceutical companies, Contract Manufacturing Organizations), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2101 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 95 | Figures: 76

Softgel Capsule Market Dynamics

Softgel Capsule Market Driver

  • Growing Number of Clinical Trials Boosting Softgel Capsule Use to Promote Revenue Growth
  • One of the main factors driving the softgel capsule market expansion is the increase in clinical trials testing the efficacy of soft gelatin capsules in the treatment of various illnesses. For example, InnoPharmax Inc. funded a clinical study in August 2018 with the main goal of evaluating the safety and tolerability of D07001 softgel in patients who had completed first-line chemotherapy or combined chemoradiotherapy (CCRT) for unresectable metastatic or locally advanced biliary tract cancer (BTC). Therefore, the market expansion during the forecast period would be substantially supported by such aspects that boost the use of these capsules in various conditions.

Softgel Capsule Market Restraint

  • Pharmaceutical Companies to See a Decline in Revenue as a Result of Losing their Patent Exclusivity
  • The creation, exploitation, and preservation of IP throughout its life is the major problem for healthcare organisations. To maintain their revenue streams, pharmaceutical corporations work incredibly hard to fend off patent expiration and generic competition. According to Statista 2020, the patent expiration of several important pharmaceuticals will put the revenue from prescription drugs at risk in the upcoming years. According to the report, the value of prescription pharmaceuticals was US$ 46 billion in 2019 before falling sharply to US$ 16 billion in 2020. As a result, the introduction of generics will increase competition for prescription medications, which is expected to have an impact on the softgel capsule market expansion.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Softgel Capsule Market size was valued at USD 7.62 billion in 2019 and is poised to grow from USD 7.67 billion in 2023 to USD 13.09 billion by 2031, growing at a CAGR of 7.9% in the forecast period (2024-2031).

The global softgel capsule market is consolidated in nature. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective and customized solutions for students. 'Catalent Inc.', 'EuroCaps Ltd.', 'Aenova Group', 'Sirio Pharma Co., Ltd.', 'Captek Softgel International Inc.', 'NBTY, Inc.', 'Thermo Fisher Scientific Inc.', 'Robinson Pharma, Inc.', 'Gelita AG', 'Lonza Group Ltd.', 'Nature's Bounty, Inc.', 'Soft Gel Technologies, Inc.', 'Nutrilo GmbH', 'Weihai Baihe Biology Technological Co., Ltd.', 'Patheon N.V.', 'Roxlor, LLC', 'Vitaco Health Group', 'Procaps S.A.', 'Amway Corporation', 'Nutritional Holdings Pty Ltd.'

Growing Number of Clinical Trials Boosting Softgel Capsule Use to Promote Revenue Growth

A Persistent Trend is the Growing Demand for Plant-Based Capsules

North America held the highest share in the global softgel capsule market. One of the main factors stimulating the expansion of the market in the area is the rising preference of major firms to launch products in developed North American nations. Key players aim for FDA and other regulatory body approvals to expand their client base abroad. The Europe softgel capsule market, on the other hand, generated a sizable amount of market revenue in 2021 owing to to the greater investment in the study and production of soft gelatin capsules across many European nations. During the forecast period, the softgel capsule market in Asia-Pacific is projected to expand at the highest CAGR due to much broader patient pool with a variety of chronic illnesses. Additionally, the regional expansion of key companies in the emerging economies of Asia-Pacific will boost its growth rate during the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global softgel capsule market

Report ID: SQMIG35I2101

$5,300
BUY NOW GET FREE SAMPLE